These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 31010759)

  • 1. [New insights in the pathogenesis of pulmonary arterial hypertension].
    Bordenave J; Tu L; Savale L; Huertas A; Humbert M; Guignabert C
    Rev Mal Respir; 2019 Apr; 36(4):433-437. PubMed ID: 31010759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
    Orriols M; Gomez-Puerto MC; Ten Dijke P
    Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.
    Tian W; Jiang X; Sung YK; Shuffle E; Wu TH; Kao PN; Tu AB; Dorfmüller P; Cao A; Wang L; Peng G; Kim Y; Zhang P; Chappell J; Pasupneti S; Dahms P; Maguire P; Chaib H; Zamanian R; Peters-Golden M; Snyder MP; Voelkel NF; Humbert M; Rabinovitch M; Nicolls MR
    Circulation; 2019 Oct; 140(17):1409-1425. PubMed ID: 31462075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension.
    Thompson AAR; Lawrie A
    Trends Mol Med; 2017 Jan; 23(1):31-45. PubMed ID: 27989641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
    Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
    Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitations.
    Guignabert C; Bailly S; Humbert M
    Expert Opin Ther Targets; 2017 Feb; 21(2):181-190. PubMed ID: 28001443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
    Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
    J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenetic protein signalling in pulmonary arterial hypertension: revisiting the BMPRII connection.
    Li W; Quigley K
    Biochem Soc Trans; 2024 Jun; 52(3):1515-1528. PubMed ID: 38716930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathobiology of pulmonary artery hypertension: role of long non-coding RNAs.
    Zahid KR; Raza U; Chen J; Raj UJ; Gou D
    Cardiovasc Res; 2020 Oct; 116(12):1937-1947. PubMed ID: 32109276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Muscle MLCK Contributes to Endothelial Cell Hyper-Proliferation through the ERK Pathway as a Mechanism for Vascular Remodeling in Pulmonary Hypertension.
    Anis M; Gonzales J; Halstrom R; Baig N; Humpal C; Demeritte R; Epshtein Y; Jacobson JR; Fraidenburg DR
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Cells in Pulmonary Arterial Hypertension.
    Ni S; Ji T; Dong J; Chen F; Feng H; Zhao H; Chen D; Ma W
    Heart Lung Circ; 2022 Jul; 31(7):934-943. PubMed ID: 35361533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): Similarities, differences and the role of autoimmunity.
    Favoino E; Prete M; Liakouli V; Leone P; Sisto A; Navarini L; Vomero M; Ciccia F; Ruscitti P; Racanelli V; Giacomelli R; Perosa F
    Autoimmun Rev; 2024 Apr; 23(4):103514. PubMed ID: 38181859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch3 signalling and vascular remodelling in pulmonary arterial hypertension.
    Morris HE; Neves KB; Montezano AC; MacLean MR; Touyz RM
    Clin Sci (Lond); 2019 Dec; 133(24):2481-2498. PubMed ID: 31868216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An organ-on-chip model of pulmonary arterial hypertension identifies a BMPR2-SOX17-prostacyclin signalling axis.
    Ainscough AJ; Smith TJ; Haensel M; Rhodes CJ; Fellows A; Whitwell HJ; Vasilaki E; Gray K; Freeman A; Howard LS; Wharton J; Dunmore B; Upton PD; Wilkins MR; Edel JB; Wojciak-Stothard B
    Commun Biol; 2022 Nov; 5(1):1192. PubMed ID: 36344664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell Death in Pulmonary Arterial Hypertension.
    Li X; Tan J; Wan J; Cheng B; Wang YH; Dai A
    Int J Med Sci; 2024; 21(10):1840-1851. PubMed ID: 39113898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulmonary arterial hypertension and BMP system abnormality].
    Otsuka F
    Nihon Rinsho; 2008 Nov; 66(11):2083-90. PubMed ID: 19051724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High relative humidity environment alleviates hypoxia-induced pulmonary arterial hypertension in mice.
    Song J; Cheng J; Ju W; Hu D; Zhuang D
    Biochem Biophys Res Commun; 2024 Nov; 733():150681. PubMed ID: 39276695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
    Antigny F; Hautefort A; Meloche J; Belacel-Ouari M; Manoury B; Rucker-Martin C; Péchoux C; Potus F; Nadeau V; Tremblay E; Ruffenach G; Bourgeois A; Dorfmüller P; Breuils-Bonnet S; Fadel E; Ranchoux B; Jourdon P; Girerd B; Montani D; Provencher S; Bonnet S; Simonneau G; Humbert M; Perros F
    Circulation; 2016 Apr; 133(14):1371-85. PubMed ID: 26912814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.